Hook & thesis
Lockheed Martin is on a temporary down-leg: the stock sits near $606 after a pullback from its 52-week high of $692, but the underlying business profile - a $194 billion identifiable backlog, consistent free cash flow, and multiyear program visibility - argues for a measured buy. I view a move to $843 as a realistic re-rating if program wins and contract conversion continue, and if the market begins to price Lockheed more on durable cash flow and backlog visibility than near-term cyclicality.
The trade here is straightforward: buy at $615.84, target $843, stop at $560. The combination of a large backlog, healthy free cash flow generation and multiple macro catalysts (defense budgets, renewed space spending) supports a re-rating from a mid-to-high 20s P/E to the high 30s if execution remains intact. The plan is intended for a long-term horizon (180 trading days) and to be managed tightly against program risk and margin outcomes.
What Lockheed Martin does and why the market should care
Lockheed Martin is a global security and aerospace company with four segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. It designs and sustains combat aircraft, missile systems, ship and radar solutions, and satellites. Investors should care because Lockheed combines visible, multi-year government contract revenue with a large install base and high switching costs. That mix creates a fairly predictable cash flow stream and a sizable backlog that can convert into revenue and margin upside when defense budgets expand or when discrete space and missile-defense programs pick up pace.
Key business and financial evidence
Use the following figures to anchor the thesis:
| Metric | Reported figure |
|---|---|
| Share price (recent) | $606.17 (current price), $615.84 (previous close) |
| Market cap | $139.47B |
| Trailing EPS | $21.77 |
| Trailing P/E | ~28.3 |
| Free cash flow | $6.908B |
| Backlog (news-cited) | $194B |
| Dividend yield | ~2.2% |
| Debt to equity | 3.23 (high leverage) |
| RSI / Momentum | RSI ~38 (weak), MACD negative |
Two numbers deserve particular emphasis. First, the $194 billion backlog gives Lockheed visibility into future revenue and creates a measurable pathway to earnings and cash flow if programs convert on schedule. Second, free cash flow of about $6.9 billion annually provides room for dividends, buybacks, and program investment - the kinds of items that can support a premium valuation if growth and margins improve.
Valuation framing - how $843 is plausible
Today Lockheed trades at a trailing P/E in the high 20s and a market cap near $139.5B. A move to $843 would lift market cap to roughly $191B (about a 37% price rise from the $615.84 reference) and imply a trailing P/E near 38.7 (using trailing EPS $21.77). That is a meaningful re-rate, but not unprecedented for high-quality defense contractors when revenue visibility improves and backlog converts into higher-margin phases of programs.
Put differently: the target values Lockheed closer to 1x its backlog on a market-cap basis (target market cap roughly in the $190B area vs a backlog of $194B). If the market starts assigning more weight to the backlog and to recurring sustainment revenue - and if free cash flow ramps - a move to those multiples can be justified. Conversely, the target implies investors must be comfortable paying a premium for durability and secular exposure to space and missile defense.
Catalysts (what can drive the re-rate)
- Government spending tailwinds - ongoing conversations and proposals for higher defense budgets could push new awards or accelerate existing programs. Recent coverage notes aggressive defense budget proposals that would benefit prime contractors.
- Space program nominations and awards - NASA's commercial lunar plans announced on 03/30/2026 increase program opportunities across primes; Lockheed's Space segment is positioned to win follow-on work.
- Backlog conversion - steady wins and milestones on programs (e.g., missile defense, satellites, aircraft sustainment) that translate backlog into recognized revenue and margin expansion.
- Operational leverage and margin improvement - if Aeronautics and MFC return higher margins as production rates rise, free cash flow per share can expand materially.
- Macro: smart weapons and precision-guided munitions market growth - sector forecasts through 2031 point to above-market CAGR in areas where Lockheed participates.
Trade plan - exacts, horizon and rationale
Entry: buy at $615.84. This aligns with the last close and provides a clear execution reference.
Target: $843.00. This represents a re-rating to a trailing P/E near the high 30s and a market cap roughly in-line with the company's backlog.
Stop loss: $560.00 - below recent support, preserving capital if program slippage or budget signals deteriorate.
Horizon: long term (180 trading days). I expect the move to play out over multiple program milestones, award announcements and budget clarity cycles. The target is not an event-driven sprint; it requires time for backlog conversion, margin normalization and for investors to re-price durable cash flows.
Position sizing should account for the company’s leverage and program risk. The stop is set to cap losses while allowing the trade room for normal volatility around large contract announcements.
Technicals & sentiment
Technically the name is soft: the 10- and 20-day SMAs sit above the current price, RSI is ~38 indicating room to recover from a mild oversold condition, and MACD is in bearish momentum. Short interest has fluctuated but days-to-cover is low (~1.5 days in recent reads), limiting the probability of a large short-squeeze. The current technical setup favors a measured entry after signs of program-specific catalysts or stabilization in the 50-day EMA.
Risks and counterarguments
- Procurement and timing risk - awards, milestone payments and program timing are dictated by government calendars. Delays or phased awards could materially push out revenue recognition and compress near-term earnings.
- Valuation stretch - the stock already trades at a trailing P/E in the high 20s. A move to the mid-to-high 30s assumes margin expansion and reliable backlog conversion; absent that, multiple compression is a real risk.
- Leverage and balance sheet risk - debt to equity around 3.23 suggests significant leverage. If interest rates or funding costs rise, or if cash flow underperforms, balance-sheet pressure could constrain capital return programs and multiple expansion.
- Policy and political risk - defense budgets can shift with administration priorities and fiscal politics; an unexpected decline or reallocation could reduce awards or delay programs.
- Supply chain & execution risk - ongoing semiconductor or specialty-component shortages could slow production cadence and inflate costs, compressing margins.
Counterargument: skeptics will point out that the stock has already rallied sharply year-to-date and trades at lofty multiples versus its historical baseline; JPMorgan and other commentators have highlighted procurement rigidities and execution constraints. If those structural constraints persist and Lockheed cannot convert backlog into incremental margin, the premium implied by $843 will not materialize.
What would change my mind
I would downgrade the trade if I saw any of the following: (1) a material contract cancellation or significant milestone deferral; (2) a persistent decline in free cash flow below the $6.9B run rate without credible plan to recover; (3) signs that backlog is being repriced downward; or (4) a sustained widening of leverage metrics driven by acquisitions or higher-than-expected financing costs. Conversely, a string of program awards, positive margin guidance and confirmed budget increases would reinforce the thesis and make me consider tightening the stop or adding to the position.
Conclusion
Lockheed is a classic large-cap defense compounder: high backlog, strong FCF and durable demand drivers, but also visible execution and policy risk. The trade to $843 is a view that the market will re-rate Lockheed on durable cash flow and backlog conversion over the next 180 trading days. Entry at $615.84, a $560 stop and $843 target balances upside capture with disciplined risk control. This is not a momentum sprint - it is a measured, event-driven re-rating trade that pays to be patient but firm about downside protection.
Key takeaways
- Buy at $615.84; target $843; stop $560; horizon long term (180 trading days).
- $194B backlog and ~$6.9B free cash flow underpin the re-rate argument.
- Valuation would move to a trailing P/E near ~38.7 at the target - demanding but reachable if backlog converts and margins expand.
- Manage position size; watch contract milestones and budget signals closely.